Primary radiotherapy for nonsurgically managed Stage I endometrial cancer: Utilization and impact of brachytherapy

被引:24
|
作者
Gill, Beant S. [1 ]
Chapman, Bhavana V. [1 ]
Hansen, Karyn J. [2 ]
Sukurnvanich, Paniti [2 ]
Beriwal, Sushil [1 ]
机构
[1] Univ Pittsburgh, Med Ctr, Magee Womens Hosp, Dept Radiat Oncol, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Med Ctr, Magee Womens Hosp, Dept Gynecol Oncol, Pittsburgh, PA 15213 USA
关键词
Brachytherapy; Inoperable; Endometrial cancer; Utilization; NCDB; DOSE-RATE BRACHYTHERAPY; RADIATION-THERAPY; CERVICAL-CANCER; DATA-BASE; INOPERABLE PATIENTS; CARCINOMA; EXPERIENCE;
D O I
10.1016/j.brachy.2014.12.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: The National Cancer Data Base (NCDB.) was analyzed to evaluate practice patterns. and the impact of radiotherapy modalities for endometrial cancer treated with primary radiotherapy. METHODS AND MATERIALS: The NCDB was queried for Stage I endometrioid adenocarcinoma patients treated with primary radiotherapy without surgery from 1998 to 2006. Brachytherapy (BT) utilization factors were established using multivariable logistic regression. Log-rank and Cox proportional hazards modeling were used to assess variables impacting survival. RESULTS: A total of 853 patients were analyzed: 23.7%, 31.3%, and 45.0% received BT alone, external beam radiotherapy (EBRT) and BT, or EBRT alone. The BT utilization ranged from 40.5% to 51.9% over time (p = 0.70). Lower utilization was associated with advanced age (>= 80 years: odds ratio [OR] 0.43, 95% confidence interval [CI] 0.28-0.65, p < 0.01) and facilities with volume in the bottom quartile (OR 0.44,. 95% CI 0.30-0.66, p < 0.01). Utilization was higher among patients living more than 30 miles from the facilities (OR 2.14, 95% CI 1.35-3.42, p < 0.01). With 36-month median followup, unadjusted median survivals for EBRT dose of 30 Gy or lower, EBRT dose higher than 30 Gy, BT, and EBRT BT were 12.6, 31.1, 44.6, and 57.1 months (p < 0.01). After correcting for other factors, higher risk of mortality was seen with EBRT dose of 30 Gy or lower (hazard ratio [HR] 2.75, 95% CI 1.66-4.55, p < 0.01) and EBRT dose higher than 30 Gy (HR 1.43, 95% CI 1.07-1.91, p = 0.02) compared with EBRT BT. No difference was seen using BT alone (HR 1.29, 95% CI 0.92-1.79, p = 0.14). CONCLUSION: BT utilization for nonsurgically managed endometrial cancer remains low with most patient's receiving EBRT alone. Despite concerns of overtreatment in a population with competing causes of death, BT appears to improve survival. (C) 2015 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:373 / 379
页数:7
相关论文
共 50 条
  • [1] Adjuvant radiotherapy for stage I endometrial cancer
    Kong, Anthony
    Johnson, Nick
    Kitchener, Henry C.
    Lawrie, Theresa A.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (04):
  • [2] Adjuvant radiotherapy for stage I endometrial cancer
    Kong, Anthony
    Johnson, Nick
    Kitchener, Henry C.
    Lawrie, Theresa A.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (03):
  • [3] Vaginal brachytherapy management of stage I and II endometrial cancer
    van den Heerik, Anne Sophie V. M.
    Horeweg, Nanda
    Creutzberg, Carien L.
    Nout, Remi A.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (03) : 304 - 310
  • [4] Adjuvant radiotherapy for stage I endometrial cancer (Review)
    Kong, A.
    Johnson, N.
    Cornes, P.
    Simera, I
    Collingwood, M.
    Williams, C.
    Kitchener, H.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (02):
  • [5] ADJUVANT BRACHYTHERAPY AND PERCUTANEOUS RADIOTHERAPY FOLLOWING PRIMARY SURGERY OF ENDOMETRIAL CANCER
    WILLGEROTH, F
    [J]. GYNAKOLOGE, 1994, 27 (02): : 76 - 83
  • [6] Radiotherapy improves survival in stage I endometrial cancer
    Ahmad, K
    [J]. LANCET ONCOLOGY, 2006, 7 (03): : 198 - 198
  • [7] Impact of vaginal brachytherapy on survival in stage I endometrioid endometrial carcinoma
    AlHilli, Mariam
    Amarnath, Sudha
    Elson, Paul
    Rybicki, Lisa
    Dowdy, Sean
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (06) : 789 - 796
  • [8] Overuse of external beam radiotherapy for stage I endometrial cancer
    Wright, Jason D.
    Margolis, Benjamin
    Hou, June Y.
    Burke, William M.
    Tergas, Ana I.
    Huang, Yongmei
    Hu, Jim C.
    Ananth, Cande V.
    Neugut, Alfred I.
    Hershman, Dawn L.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 215 (01) : 75.e1 - 75.e7
  • [9] Survival outcomes following adjuvant radiotherapy with and without brachytherapy in stage IIIC endometrial cancer
    Clark, Helen
    Huang, YongMei
    de Meritens, Alexandre Buckley
    Khoury-Collado, Fady
    Hou, June
    Clair, Caryn St.
    Wright, Jason
    [J]. GYNECOLOGIC ONCOLOGY, 2023, 176 : S115 - S116
  • [10] The role of preoperative brachytherapy as an adjunct to surgery and postoperative radiotherapy in the treatment of stage I endometrial carcinoma
    Póka, R
    Szluha, K
    Lampé, L
    Urbancsek, H
    Borsos, A
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2000, 92 (02) : 241 - 249